Pulse Oximetry Reporting and Meaningful Use
Eligible Hospitals enrolled in the Medicare and Medicaid EHR Incentive Program may elect to report electronic HL7 pulse oximetry reports on screening for Critical Congenital Heart Disease (CCHD) to the Michigan Department of Health and Human Services (MDHHS) Newborn Screening Program, fulfilling the Public Health Objective Specialized Registry Measure.
Why Support HL7 Messaging for Reporting of CCHD?
Based upon a recent ruling from the Centers for Medicare and Medicaid Services, hospitals are required to select 3 public health measures to comply with the Meaningful Use public health measures. One of these measures is reporting to a Specialized Registry. By submitting electronic HL7 pulse oximetry reports to the MDHHS Newborn Screening Program a hospital meets the definition of submitting to a Specialized Registry.
Additional benefits of HL7 messaging for reporting CCHD include:
- Reducing staff time
- Decreasing reporting errors
- Allowing real time reporting of CCHD screening results
- Coordinating HL7 messaging for Newborn Screening card demographics and results reporting coming in the near future
For more information, please visit Michigan’s Critical Congenital Heart Disease Newborn Screening Program.
Criteria for Meaningful Use Reporting
Eligible hospitals must meet the following criteria to in order to select pulse oximetry reporting as a Specialized Registry Measure.
- Have a Birthing Facility
- Capability to Submit Pulse Oximetry Results in the Standard Format
A Health Level Seven (HL7) national standard has been developed for critical congenital heart defect pulse oximetry results. The Michigan Newborn Screening Program has developed a supplemental implementation guide. Hospitals should prepare to submit the results in accordance with the Michigan Newborn Screening for CCHD Implementation Guide.
Meaningful Use Registration to Report Pulse Oximetry Results
Eligible hospitals with birthing facilities electing to report pulse oximetry results for the Specialized Registry Measure must complete a registration within 60 days of the start of the meaningful use reporting period.
Instructions for completing the registration: Registration can be completed by sending an email to NBS.Help@Altarum.org or calling (734) 302-4933 with intent to utilize the registry.
Once the registration is completed, an e-mail will be sent with instructions on next steps to comply with meaningful use active engagement requirements.
View and download the Newborn Screening 5 Step Pulse Oximetry Reporting Meaningful Use Process
Contact Us for Assistance
Early Hearing Detection and Intervention (EHDI)
The Michigan Early Hearing Detection & Intervention (EHDI) Program’s goals are to provide better outcomes for Michigan newborns and young children with hearing loss and their families, through early hearing screening, appropriate audiological diagnosis, and intervention. This guide covers the initial EHDI screening (no later than 1 month of age, preferably before hospital discharge). The MDHHS Newborn EHDI HL7 Guide is still in draft and is being release for comments only. Comments should be sent to firstname.lastname@example.org with the subject “MDHHS Newborn EHDI HL7 Guide Comments.”
Download the MDHHS Newborn EHDI Guide:
EHDI Initial Screening is targeted to be available as a Specialized Registry in 2017.